Background
==========

Bovine leukemia virus (BLV), a retrovirus related to human T-cell leukemia virus types 1 and 2 (HTLV-1 and HTLV-2), causes enzootic bovine leukosis, a disease characterized by a very extended course that often involves persistent lymphocytosis (PL) and culminates in B-cell lymphoma \[[@B1]\]. BLV encodes the regulatory proteins Tax and Rex, which contribute to infectious potential and the regulation of viral expression \[[@B2],[@B3]\]. The Tax protein acts on a triplicate 21-bp enhancer motif known as the Tax-responsive element (TxRE) in the U3 region of the 5^′^long terminal repeat (LTR), and it stimulates transactivation of the viral genome \[[@B2],[@B4]\]. The TxRE consists of a cyclic AMP-response element (CRE)-like sequence, and Tax has been suggested to bind indirectly to this element through cellular factors, such as members of the CREB/activating transcription factor (ATF) family of basic leucine zipper proteins that have been shown to bind to the CRE-like sequence \[[@B5]-[@B7]\]. The Tax protein is also known to modulate the expression of cellular genes that are related to the regulation of cell growth \[[@B8]\]. Tax induces the immortalization of primary rat embryo fibroblasts and cooperates with the Ha-*ras* oncogene to induce the full transformation of cells that form tumors when injected into nude mice, a property shared by the G4 protein of BLV \[[@B9],[@B10]\]. Furthermore, the expression of Tax in primary ovine B lymphocytes, which depends on CD154 and interleukin-4, affects B lymphocyte proliferation, cell cycle phase distribution, and survival, leading to cytokine-independent growth \[[@B11]\]. This immortalization process is also correlated with increased Bcl-2 protein levels, nuclear NF-κB accumulation, and a series of intracellular pathways that remain to be characterized \[[@B12]\]. In addition, Tax BLV inhibits base-excision DNA repair of oxidative damage, potentially increasing the accumulation of ambient mutations in cellular DNA \[[@B13]\]. To further understand the mechanisms of action, the identification of Tax-associated host cellular factors and pathways is now essential.

Our group has previously identified a Tax mutant in BLV that stimulates viral LTR-directed transcription via the BLV enhancer, and the extent of stimulation by this mutant is significantly greater than that of wild-type Tax and also that of a defective mutant that lacks this capacity \[[@B14]\]. The mutants have missense mutations in residues 247 (Tax~D247G~) and 240 (Tax~S240P~) that confer high and defective transactivation ability to the mutants, respectively \[[@B14]\]. Furthermore, it has been shown that Tax~D247G~ but not wild-type Tax protein activates the upstream sequence of the human cellular proto-oncogene c-*fos*, which contains 2 major *cis*-acting elements---the CArG box and CRE motif indispensable for the activation of *c-fos* by the mutant Tax protein---and also increases the levels of endogenous c- *fos* mRNA considerably in both human and bovine cell lines \[[@B8]\], suggesting that Tax~D247G~ might have the ability to activate the production of virus particles and an enhanced ability to induce leukemia/lymphosarcoma compared with wild-type Tax protein. Interestingly, we observed that an infectious molecular clone of BLV that encodes the Tax~D247G~ protein produced more viral particles and was transmitted at an elevated rate *in vitro*, but with no significant differences in the viral load and the expression of viral RNA between sheep experimentally injected with BLVs that encode the wild-type and mutant Tax~D247G~ proteins \[[@B15]\], suggesting a possible mechanism for regulating BLV--LTR--directed transcription by Tax that may play an important role in viral silencing *in vivo*. In addition, it appears that Tax protein has the capacity to participate in the induction and inhibition of cell survival *in vitro* and *ex vivo*, respectively, and mutant Tax protein caused greater stimulation than wild-type Tax protein did \[[@B16],[@B17]\]. The enhanced activity of such a mutant Tax protein might be due to alterations in the interactions between Tax and cellular factors owing to the change in the amino acid sequence between amino acids 240 and 265. However, the mechanism by which such mutations increase the activity of Tax and the cellular factors involved in this process remains unknown.

The advent of microarray technology, coupled with the availability of comprehensive databases of gene identity and function, has made it possible to examine transcriptional changes across a landscape of thousands of genes. The human genome is almost fully annotated, and thus, chips representing all of the annotated genes are commercially available. By contrast, the quality of commercially and custom-made genome-wide microarrays is still poor because of the limited availability of full-length cDNA sequences in cattle. In this study, in an attempt to identify genes that play a role in the cascade of signal events regulated by wild-type Tax (Tax~WT~) and mutant Tax with high (Tax~D247G~) and defective transactivation activity (Tax~S240P~), we used a large-scale host cell gene-profiling approach using human cDNA microarrays. Furthermore, we chose human HeLa cells, which have been extensively characterized regarding the host factors involved in various cellular functions as a model system for analysis of bovine Tax proteins; isolated total RNA from HeLa cells had been transfected with expression vectors encoding Tax~WT~, Tax~S240P~, Tax~D247G~, or control vector; and subjected each RNA sample to human microarray analysis. The genomic expression profiling resulted in the identification of approximately 300 genes up- and downregulated by wild-type and mutant Tax proteins. Finally, the expression of important transcriptional cellular factors indicated by the human microarray results were validated after the transfection of wild-type or mutant Tax proteins into bovine cells as well as human HeLa cells.

Results
=======

Expression of wild-type and mutant tax proteins in HeLa cells
-------------------------------------------------------------

To measure alterations in the expression of host cellular genes regulated by wild-type and mutant Tax proteins with elevated (D247G) and reduced (S240P) transactivation activity, we constructed pCAGGS mammalian expression vectors encoding Tax proteins (Tax~WT~, Tax~S240P~, and Tax~D247G~) that were Flag-tagged at their carboxy termini to facilitate the assay, and these vectors were transfected into human cervical HeLa cells. At 24 h after transfection, we examined the expression of each Tax protein by western blotting using monoclonal antibody (MAb) M2, which recognizes the Flag tag (Figure [1](#F1){ref-type="fig"}A). We observed a single band for each of the 3 vector constructs, and found no difference in protein expression between wild-type and mutant Tax proteins in repeated experiments. As shown in Figure [1](#F1){ref-type="fig"}B, all Tax proteins exhibited greater cytoplasmic localization than nuclear localization and exhibited punctate staining patterns in the majority of transfected HeLa cells, as previously described by \[[@B18]\]. To clarify the transactivation capacity of mutant Tax proteins, we transfected HeLa cells with Tax expression vectors plus the reporter plasmid pGV-BLTR, which expressed the full-length BLV LTR upstream of the luciferase gene, and then, we analyzed the luciferase activity (Figure [1](#F1){ref-type="fig"}C). Tax~D247G~ was able to induce higher viral LTR-directed transcriptional activation than the Tax~WT~, in contrast to Tax~S240P~, which markedly reduced this activity, in line with the result of our previous study using 293 T cells \[[@B14]\]. Thus, we confirmed that there was no obvious relationship between transactivation activity and the expression, stability, and localization of Tax proteins in HeLa cells. Therefore, we used HeLa cells in subsequent microarray experiments.

![**Expression, localization, and transactivation of wild-type and mutant Tax proteins in HeLa cells.** HeLa cells were transfected with pCAGGS encoding Flag-tagged Tax proteins (Tax~WT~, Tax~S240P~, or Tax~D247G~) or the control pCAGGS without (**A** and **B**) or with the reporter plasmid pGV-BLTR and the reference plasmid pRL-SV40 ( **C**). Thereafter, 24 h after transfection, cells were subjected to western blotting ( **A**), confocal laser-scanning analysis ( **B**), and the firefly luciferase assay ( **C**). ( **A**) Western blotting was performed using an anti-Flag M2 MAb and anti-actin antibody as a control. ( **B**) For immunofluorescence, cells were fixed, permeabilized, and immunostained with anti-Flag M2 MAb followed by the Alexa-488-conjugated anti-mouse antibody (green). ( **C**) For the transactivation assay, cells were recovered and lysed, and the activities of firefly and *Renilla* luciferase were measured. For each sample, the firefly luciferase activity (pGV-BLTR) was normalized by reference to *Renilla* luciferase activity (pRL-SV40). Average values from triplicate transfections with standard deviations (error bars) are shown (\*p \< 0.01).](1471-2164-13-121-1){#F1}

Large-scale expression profiling of cellular genes after the transfection of wild-type and mutant tax proteins
--------------------------------------------------------------------------------------------------------------

To analyze the transcriptional effects by wild-type and mutant Tax proteins on global gene expression, total RNA was isolated from HeLa cells that had been transfected with Tax~WT~, Tax~S240P~, Tax~D247G~, or control vector, and each RNA sample was subjected to microarray analysis. Additionally, to ensure equivalent transfection efficiency, we simultaneously assessed the expression of all Tax proteins and confirmed same efficiency in our samples (data not shown). After microarray analysis, data sets were analyzed using GeneSpring GX 11.0 software for gene expression, clustering, gene ontology, and significant pathway signaling. Using DNA microarrays containing approximately 18,400 mRNA transcripts in each array, we identified over 300 genes hierarchically clustered for all samples (Figure [2](#F2){ref-type="fig"}A). Among them, 122 (90 were upregulated and 32 were downregulated), 118 (64 were upregulated and 54 were downregulated), and 139 genes (95 were upregulated and 44 were downregulated) exhibited statistically significant differential regulation (2-fold or more) by Tax~WT~, Tax~S240P~, and Tax~D247G~, respectively (p \< 0.05) (Figure [2](#F2){ref-type="fig"}B). The mutant Tax~S240P~ induced more variation in whole gene expression, as noted by the colors in the heat map (Figure [2](#F2){ref-type="fig"}A), which indicated that this mutant upregulated (red) fewer genes and downregulated (blue) more genes than the other Tax proteins did. The numbers of genes up- and downregulated by Tax~WT~ or Tax~D247G~ were similar, but the intensity of the expression changes was slightly stronger in the case of Tax~D247G~.

![**Differential expression of cellular genes after induction of wild-type and mutant Tax proteins in HeLa cells.** Total RNA from HeLa cells transfected with pCAGGS encoding Tax proteins (Tax~WT~, Tax~S240P~, or Tax~D247G~) or the control pCAGGS was used for the microarray analysis. (**A**) Heat map of hierarchical gene clustering. The microarray data was analyzed using GeneSpring GX 11.0 software to obtain the hierarchical clustering. The columns correspond to gene profiles regulated by the different Tax proteins indicated above the map. Below the heat map is a color-coded scale bar for the relative expression levels of genes. ( **B**) Number of genes significantly up- or downregulated by wild-type and mutant Tax proteins. The genes shown in this figure passed 2 filtering criteria: (1) statistical significance (p \< 0.05) and (ii) at least 2-fold changes in the expression of a cellular gene at least 1 time point.](1471-2164-13-121-2){#F2}

Analysis of gene ontology annotations revealed the number of genes grouped according to biological functions that were upregulated by wild-type and mutant Tax proteins by at least 2-fold (p \< 0.05) (Figure [3](#F3){ref-type="fig"}). The upregulated genes were clustered within functional groups involved in transcription/translation/RNA processing, cell growth/proliferation, signal transduction, transport, phosphorylation, apoptosis, stress response, metabolic processes, and cell adhesion. Interestingly, we found that Tax~D247G~ regulated more genes involved in transcription/translation/RNA processing functions, contrary to Tax~S240P~, which regulated fewer genes (Figure [3](#F3){ref-type="fig"}). As shown in Table [1](#T1){ref-type="table"}, Tax~D247G~ induced higher expression for the following genes than Tax~WT~ and Tax~S240P~ did: genes involved in transcription/translation/RNA processing such as CREM, FOS, NR4A2, RORA*,* MAFB, and MAFF; genes involved in signal transduction such as GEM, GNB5, PITPNC1, RGS5, and RRAD; genes involved in cell growth/cell proliferation such as CYR61, EMP3, and IL11; TNFAIP6, which is involved in immune responses; NPTX1, which is involved in transport; PHLDA1, which is involved in apoptosis; and DUSP1, which is a dual specificity serine/threonine phosphatase. All these genes were expressed at lower level in cells transfected with Tax~S240P~, which indicated the reduced transactivation activity of Tax~S240P~ compared to that of Tax~WT~ or Tax~D247G~. By contrast, the expression of DNAJB1, HSPA1A, and HSPA6, which respond to stress, was significantly increased in the presence of Tax~S240P~ compared to that in the presence of the other Tax proteins. There were no differences in the expression levels of genes related to apoptosis, such as IER3, TNFRSF12A, and NFRSF21; genes related to transcription/translation/RNA processing, such as ETV5 and JUN; and genes related to signal transduction, such as GDF15, induced by the Tax proteins. Thus, we confirmed that our mutant Tax~D247G~ strongly induced the expression of cellular factors involved in transcription/translation/RNA processing, signal transduction, and cell growth/cell proliferation, whereas the mutant Tax~S240P~ could not induce these genes at high expression levels. Our result also shows that the mutant Tax~S240P~ upregulated genes related to stress responses.

![**Ontology annotations of differentially expressed genes after the transfection of wild-type and mutant Tax proteins.** Classification of up- or downregulated genes involved in biological functions with significant differential expression (fold change \> 2.0 and p \< 0.05). Tax~WT,~ open column; Tax~S240~, shaded column; Tax~D247G~, black column.](1471-2164-13-121-3){#F3}

###### 

Genes upregulated in the total RNA fraction in the presence of wild-type and mutant Tax proteins

  **Gene ID**   **Gene description**                                                      **Gene Symbol**   **Fold Change**          
  ------------- ------------------------------------------------------------------------- ----------------- ----------------- ------ ------
                **Transcription/Translation/RNA processing**                                                                          
  1390          cAMP responsive element modulator                                         CREM              2.2               1.8    3.2
  1958          early growth response 1                                                   EGR1              1.9               2.0    1.7
  22936         elongation factor, RNA polymerase II, 2                                   ELL2              2.2               2.2    2.2
  2119          ets variant 5                                                             ETV5              3.7               3.6    3.4
  2353          FBJ murine osteosarcoma viral oncogene homolog                            FOS               3.7               2.4    4.6
  8061          FOS-like antigen 1                                                        FOSL1             2.4               2.4    2.3
  3280          Hairy and enhancer of split 1 (Drosophila)                                HES1              1.8               1.9    2.0
  3725          jun oncogene                                                              JUN               4.7               5.9    5.3
  10365         Kruppel-like factor 2 (lung)                                              KLF2              2.6               2.6    2.8
  1316          Kruppel-like factor 6                                                     KLF6              2.1               2.1    2.1
  9935          v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)          MAFB              2.6               1.9    3.8
  23764         v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)          MAFF              2.4               1.9    2.6
  4929          nuclear receptor subfamily 4, group A, member 2                           NR4A2             3.6               1.5    7.7
  57157         Putative homeodomain transcription factor 2                               PHTF2             1.9               1.9    2.0
  6095          RAR-related orphan receptor A                                             RORA              10.3              2.0    10.6
  7538          zinc finger protein 36, C3H type, homolog (mouse)                         ZFP36             2.8               2.6    2.6
                **Signal Transduction**                                                                                               
  287           ankyrin 2, neuronal                                                       ANK2              2.0               2.0    1.4
  9518          growth differentiation factor 15                                          GDF15             5.0               4.9    5.6
  2669          GTP binding protein over expressed in skeletal muscle                     GEM               14.3              5.0    19.1
  10681         guanine nucleotide binding protein (G protein), beta 5                    GNB5              2.0               1.2    2.4
  2786          guanine nucleotide binding protein (G protein), gamma 4                   GNG4              1.8               2.0    1.6
  26207         phosphatidylinositol transfer protein, cytoplasmic 1                      PITPNC1           1.9               1.7    2.5
  5329          plasminogen activator, urokinase receptor                                 PLAUR             2.0               1.7    1.9
  5521          protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoform   PPP2R2B           1.3               1.0    2.1
  5997          regulator of G-protein signaling 2, 24 kDa                                RGS2              2.4               1.1    2.4
  6004          regulator of G-protein signaling 16                                       RGS16             2.0               2.0    2.0
  6236          Ras-related associated with diabetes                                      RRAD              3.8               2.3    7.9
  81848         sprouty homolog 4 (Drosophila)                                            SPRY4             1.9               2.1    1.9
                **Inflammatory response/Immune response**                                                                             
  2921          chemokine (C-X-C motif) ligand 3                                          CXCL3             1.8               2.0    1.8
  3269          histamine receptor H1                                                     HRH1              2.5               1.7    1.8
  7130          tumor necrosis factor, alpha-induced protein 6                            TNFAIP6           20.5              1.3    36.6
                **Regulation of cell growth/Regulation of cell proliferation**                                                        
  183           angiotensinogen (serpin peptidase inhibitor, clade A, member 8)           AGT               1.3               1.3    2.3
  374           amphiregulin                                                              AREG              2.0               2.1    2.3
  694           B-cell translocation gene 1, anti-proliferative                           BTG1              3.3               1.1    3.0
  6347          chemokine (C-C motif) ligand 2                                            CCL2              2.0               1.6    1.6
  960           CD44 molecule (Indian blood group)                                        CD44              2.1               2.0    2.3
  3491          cysteine-rich, angiogenic inducer, 61                                     CYR61             4.8               2.0    7.5
  2014          epithelial membrane protein 3                                             EMP3              1.8               1.2    3.1
  3589          interleukin 11                                                            IL11              3.6               1.7    5.4
  83729         inhibin, beta E                                                           INHBE             2.1               3.0    1.9
  182           jagged 1                                                                  JAG1              2.1               1.8    2.3
  3976          leukemia inhibitory factor (cholinergic differentiation factor)           LIF               2.2               2.2    2.2
                **Apoptosis**                                                                                                         
  56892         chromosome 8 open reading frame 4                                         C8orf4            1.2               1.2    2.3
  8870          immediate early response 3                                                IER3              3.3               3.2    3.7
  22822         pleckstrin homology-like domain, family A, member 1                       PHLDA1            2.5               1.9    3.2
  51330         tumor necrosis factor receptor superfamily, member 12A                    TNFRSF12A         2.0               1.9    2.0
  27242         tumor necrosis factor receptor superfamily, member 21                     TNFRSF21          2.3               2.1    2.4
                **Cell adhesion/Cell-cell adhesion**                                                                                  
  6695          sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1             SPOCK1            2.0               1.7    2.1
  6696          secreted phosphoprotein 1                                                 SPP1              1.9               2.5    2.1
                **Transport**                                                                                                         
  3039          hemoglobin, alpha 1                                                       HBA1              2.4               2.5    2.4
  4884          neuronal pentraxin I                                                      NPTX1             2.3               1.2    3.6
  6507          solute carrier family 1, member 3                                         SLC1A3            1.8               2.0    1.8
  6533          solute carrier family 6, member 6                                         SLC6A6            2.2               2.3    1.9
  23657         solute carrier family 7, member 11                                        SLC7A11           2.3               2.4    1.8
                **Metabolic process**                                                                                                 
  384           arginase, type II                                                         ARG2              3.2               3.2    3.6
  9945          glutamine-fructose-6-phosphate transaminase 2                             GFPT2             2.0               2.0    1.9
  9388          Lipase, endothelial                                                       LIPG              1.9               1.4    2.1
  7378          uridine phosphorylase 1                                                   UPP1              2.1               1.8    2.0
                **Phosphorylation/Dephosphorylation**                                                                                 
  9201          doublecortin-like kinase 1                                                DCLK1             2.1               2.0    2.1
  1843          dual specificity phosphatase 1                                            DUSP1             3.6               2.4    4.7
  51207         dual specificity phosphatase 13                                           DUSP13            2.2               1.9    2.2
  1846          dual specificity phosphatase 4                                            DUSP4             2.9               3.0    2.9
  1847          dual specificity phosphatase 5                                            DUSP5             2.4               2.4    2.8
  1848          dual specificity phosphatase 6                                            DUSP6             2.4               2.8    2.7
  5578          protein kinase C, alpha                                                   PRKCA             2.1               1.9    1.8
                **Response to stress**                                                                                                
  3337          DnaJ (Hsp40) homolog, subfamily B, member 1                               DNAJB1            2.7               3.1    2.5
  3303          heat shock 70 kDa protein 1A                                              HSPA1A            2.9               4.2    2.8
  3310          heat shock 70 kDa protein 6                                               HSPA6             6.4               15.4   5.3
                **Others/Unknown**                                                                                                    
  202           absent in melanoma 1                                                      AIM1              1.7               1.8    2.1
  23237         activity-regulated cytoskeleton-associated protein                        ARC               2.5               2.3    2.3
  1475          cystatin A (stefin A)                                                     CSTA              4.6               5.3    5.4
  56603         cytochrome P450, family 26, subfamily B, polypeptide 1                    CYP26B1           2.1               1.7    2.1
  23052         endonuclease domain containing 1                                          ENDOD1            2.0               2.1    2.1
  2201          fibrillin 2                                                               FBN2              2.1               1.6    1.8
  10324         kelch repeat and BTB (POZ) domain containing 10                           KBTBD10           3.0               1.9    2.4
  5270          serpin peptidase inhibitor, clade E, member 2                             SERPINE2          2.3               2.3    2.4
  4071          transmembrane 4 L six family member 1                                     TM4SF1            1.9               1.8    2.3
  25907         transmembrane protein 158 (gene/pseudogene)                               TMEM158           2.1               2.4    2.5
  7171          tropomysin 4                                                              TPM4              2.5               1.5    3.5
  7846          tubulin, alpha 1a                                                         TUBA1A            1.9               2.1    1.8

We next assessed whether the expression of wild-type and mutant Tax proteins resulted in the transcriptional downregulation of any cellular transcripts. The downregulated genes were involved in transcription/translation/RNA processing, immune response, cell growth/proliferation, apoptosis, cell cycle, transport, cell signaling, ubiquitination, and nucleosome assembly (Figure [3](#F3){ref-type="fig"}). In particular, a number of molecules involved in immune response were significantly downregulated by all of the Tax proteins. As shown in Table [2](#T2){ref-type="table"}, we found 12 downregulated genes involved in immune response and the immune response to virus infection, and interestingly, they were mainly related to the interferon family of anti-viral factors, such as IFIT1, IFIT3, and OASL. In general, the expression levels of the downregulated genes were similarly affected by the 3 Tax proteins. Thus, our results clearly demonstrated a significant negative impact of Tax on expression of genes involved in the innate immune response to viral infection.

###### 

Genes downregulated in the total RNA fraction in the presence of wild-type and mutant Tax proteins

  **Gene ID**   **Gene description**                                                     **Gene Symbol**   **Fold Change**         
  ------------- ------------------------------------------------------------------------ ----------------- ----------------- ----- ------
                **Transcription/Translation/RNA processing**                                                                        
  23741         EP300 interacting inhibitor of differentiation 1                         EID1              2.0               2.1   2.0
  2625          GATA binding protein 3                                                   GATA3             2.0               1.6   1.6
  3398          inhibitor of DNA binding 2, dominant negative helix-loop-helix protein   ID2               1.6               1.4   2.2
  23658         LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae)            LSM5              1.7               1.8   2.0
  63931         mitochondrial ribosomal protein S14                                      MRPS14            1.9               2.4   2.2
  5936          RNA binding motif protein 4                                              RBM4              1.7               2.4   2.1
  6591          snail homolog 2 (Drosophila)                                             SNAI2             1.9               2.2   1.7
                **Immune response/Response to virus**                                                                               
  23586         DEAD (Asp-Glu-Ala-Asp) box polypeptide 58                                DDX58             2.9               3.3   3.9
  79132         DEXH (Asp-Glu-X-His) box polypeptide 58                                  DHX58             2.1               2.2   2.3
  10561         interferon-induced protein 44                                            IFI44             2.1               2.7   2.8
  64135         interferon induced with helicase C domain 1                              IFIH1             2.0               2.2   2.3
  3434          interferon-induced protein with tetratricopeptide repeats 1              IFIT1             5.2               5.6   6.0
  3433          interferon-induced protein with tetratricopeptide repeats 2              IFIT2             3.1               3.7   4.2
  3437          interferon-induced protein with tetratricopeptide repeats 3              IFIT3             5.4               5.5   5.5
  9636          ISG15 ubiquitin-like modifier                                            ISG15             2.2               2.6   2.1
  8638          2\'-5\'-oligoadenylate synthetase-like                                   OASL              8.8               8.8   10.3
  445347        TCR gamma alternate reading frame protein                                TARP              1.9               3.0   1.1
  6967          T cell receptor gamma constant 2                                         TRGC2             2.1               3.4   1.2
  56829         zinc finger CCCH-type, antiviral 1                                       ZC3HAV1           2.9               2.9   3.2
                **Cell signalling**                                                                                                 
  3641          insulin-like 4 (placenta)                                                INSL4             2.4               2.7   2.5
  5122          proprotein convertase subtilisin/kexin type 1                            PCSK1             2.8               2.8   2.5
  25780         RAS guanyl releasing protein 3 (calcium and DAG-regulated)               RASGRP3           1.6               2.1   1.8
                **Nucleosome assembly**                                                                                             
  94239         H2A histone family, member V                                             H2AFV             1.9               2.0   1.9
  8334          histone cluster 1, H2ac                                                  HIST1H2AC         2.1               2.0   2.0
  8329          histone cluster 1, H2ag                                                  HIST1H2AG         1.6               2.2   1.7
  8349          histone cluster 2, H2be                                                  HIST2H2BE         1.7               2.2   1.6
                **Regulation of cell proliferation**                                                                                
  2247          fibroblast growth factor 2 (basic)                                       FGF2              3.4               3.5   3.7
  10216         proteoglycan 4                                                           PRG4              1.7               2.2   1.7
  5920          retinoic acid receptor responder (tazarotene induced) 3                  RARRES3           2.3               2.4   2.5
                **Apoptosis**                                                                                                       
  8743          tumor necrosis factor (ligand) superfamily, member 10                    TNFSF10           2.5               2.9   2.6
                **Cell cycle**                                                                                                      
  10083         Usher syndrome 1 C (autosomal recessive, severe)                         USH1C             2.0               2.0   1.7
                **Transport**                                                                                                       
  57101         anoctamin 2                                                              ANO2              1.9               2.1   2.0
  6337          sodium channel, nonvoltage-gated 1 alpha                                 SCNN1A            2.4               2.1   2.4
  6717          sorcin                                                                   SRI               2.3               2.3   2.6
                **Ubiquitin**                                                                                                       
  51191         hect domain and RLD 5                                                    HERC5             4.9               5.0   5.7
  55008         hect domain and RLD 6                                                    HERC6             2.2               2.5   2.2
                **Others/Unknown**                                                                                                  
  83990         BRCA1 interacting protein C-terminal helicase 1                          BRIP1             1.4               2.1   1.8
  79940         chromosome 6 open reading frame 155                                      C6orf155          1.5               2.1   1.5
  1601          disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)       DAB2              2.2               2.3   2.2
  55601         DEAD (Asp-Glu-Ala-Asp) box polypeptide 60                                DDX60             3.7               4.1   4.3
  2335          fibronectin 1                                                            FN1               2.0               2.5   1.8
  23387         SIK family kinase 3                                                      KIAA0999          1.2               1.2   2.2
  54809         sterile alpha motif domain containing 9                                  SAMD9             1.8               2.0   2.4
  6414          selenoprotein P, plasma, 1                                               SEPP1             2.1               2.1   2.2
  8470          sorbin and SH3 domain containing 2                                       SORBS2            2.2               2.4   2.4

Moreover, we determined which biological pathways and genes involved in these pathways were significantly affected by wild-type and mutant Tax proteins (p \< 0.05) (Table [3](#T3){ref-type="table"}). Almost all the pathways were represented by the same genes regulated by all of our Tax constructs, and these pathways and genes are involved in many transcriptional functions, such as p53 effectors, transcriptional targets of AP1 family, IL1-mediated signaling, regulation of p38 MAPK signaling, IL12-mediated signaling, IL2-mediated signaling, ATF-2 transcription factor network, JNK signaling in the CD4+ TCR pathway, and Ras signaling in the CD4+ TCR pathway (Table [3](#T3){ref-type="table"}).

###### 

Genes involved in signaling pathways regulated by wild-type and mutant Tax proteins (p \< 0.05)\*

  **Significant Pathway**                                                           **Tax**~**WT**~                         **Tax**~**S240P**~                                               **Tax**~**D247G**~
  --------------------------------------------------------------------------------- --------------------------------------- ---------------------------------------------------------------- ---------------------------------------------
  Direct p53 effectors                                                              DUSP1, DUSP5, GDF15, HSPA1A, JUN, LIF   *BDKRB2*, DUSP1, DUSP5, GDF15, HSPA1A, JUN, LIF, *SNAI2*, SPP1   DUSP1, DUSP5, GDF15, HSPA1A, JUN, LIF, SPP1
  Validated transcriptional targets of AP1 family members Fra1 and Fra2             FOS, FOSL1, GATA3, JUN, LIF, PLAUR      FOS, FOSL1, IL8, JUN, LIF                                        FOS, FOSL1, JUN, LIF
  IL1-mediated signaling events                                                     DUSP1, FOS, FOSL1, *GATA3*, JUN         DUSP1, FOS, FOSL1, IL8, JUN                                      DUSP1, FOS, FOSL1, JUN
  BMP receptor signalling                                                           DUSP1, FOS, FOSL1, *GATA3*, JUN         DUSP1, FOS, FOSL1, IL8, JUN                                      DUSP1, FOS, FOSL1, JUN
  p38 MAPK signaling pathway                                                        DUSP1, FOS, FOSL1, *GATA3*, JUN         DUSP1, FOS, FOSL1, IL8, JUN                                      DUSP1, FOS, FOSL1, JUN
  Regulation of p38-alpha and p38-beta                                              DUSP1, FOS, FOSL1, *GATA3*, JUN         DUSP1, FOS, FOSL1, IL8, JUN                                      DUSP1, FOS, FOSL1, JUN
  IL12-mediated signaling events                                                    ETV5, FOS, *GATA3*, JUN                 ETV5, FOS, IL12A, JUN                                            ETV5, FOS, JUN
  Role of Calcineurin-dependent NFAT signaling in lymphocytes                       FOS, FOSL1, *GATA3*, JUN                FOS, FOSL1, IL8, JUN                                             FOS, FOSL1, JUN
  Calcineurin-regulated NFAT-dependent transcription in lymphocytes                 FOS, FOSL1, *GATA3*, JUN                FOS, FOSL1, IL8, JUN                                             FOS, FOSL1, JUN
  FOXM1 transcription factor network                                                ETV5, FOS, HSPA1A                       ETV5, FOS, HSPA1A                                                ETV5, FOS, HSPA1A
  xef;ve CD4+ T cells                                                               FOS, FOSL1, JUN                         FOS, FOSL1, JUN                                                  FOS, FOSL1, JUN
  CXCR4-mediated signaling events                                                   FOS, FOSL1, JUN                         FOS, FOSL1, JUN                                                  FOS, FOSL1, JUN
  Glucocorticoid receptor signaling                                                 FOS, *GATA3*, JUN                       FOS, IL8, JUN                                                     
  ATF-2 transcription factor network                                                DUSP1, DUSP5, JUN                       DUSP1, DUSP5, IL8, JUN                                           DUSP1, DUSP5, HES1, JUN
  JNK signaling in the CD4+ TCR pathway                                             FOSL1, JUN                              FOS, FOSL1, JUN                                                  FOS, FOSL1, JUN
  Ras signaling in the CD4+ TCR pathway                                             FOS, FOSL1, JUN                         FOS, FOSL1, JUN                                                  FOS, FOSL1, JUN
  xef;ve CD8+ T cells                                                               FOS, FOSL1, JUN                         FOS, FOSL1, JUN                                                  FOS, FOSL1, JUN
  Calcium signaling in the CD4+ TCR pathway                                         FOS, FOSL1, JUN                         FOS, FOSL1, JUN                                                  FOS, FOSL1, JUN
  Regulation of Wnt-mediated beta catenin signaling and target gene transcription   CYR61, JUN                              IL8, JUN, *SNAI2*                                                CYR61, *ID2*, JUN
  IL2-mediated signaling events                                                     FOS, JUN                                FOS, JUN                                                         FOS, JUN
  ErbB2/ErbB3 signaling events                                                      FOS JUN                                 FOS, JUN                                                         FOS, JUN
  BCR signaling pathway                                                             FOS, JUN                                FOS, JUN                                                         FOS, JUN
  IL12 signaling mediated by STAT4                                                  ETV5, JUN                               ETV5, JUN                                                        ETV5, JUN
  PDGFR-alpha signaling pathway                                                     FOS, JUN                                FOS, JUN                                                         FOS, JUN
  Integrins in angiogenesis                                                         CD44, *FGF2*                            CD44, *FGF2*, SPP1                                               CD44, *FGF2*, SPP1
  amb2 Integrin signalling                                                          CYR61, PLAUR                                                                                              

\*Up- or downregulated genes are represented by regular or italic characters, respectively.

Validation of the expression of host cellular genes at the RNA and protein levels in HeLa cells
-----------------------------------------------------------------------------------------------

To validate the microarray data after overexpression of wild-type and mutant Tax proteins in HeLa cells, we assessed the expression of several transcriptional cellular factors at the RNA and protein levels (Figure [4](#F4){ref-type="fig"}). First, real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to corroborate the fold changes obtained from the microarray results. In performing this assay, we chose significantly upregulated genes in 4 categories: transcription/translation/RNA processing (FOS, JUN, NR4A2, and RORA), signal transduction (GEM and RRAD), immune response (TNFAIP6), and regulation of cell growth and cell proliferation (CYR61). The qRT-PCR results for these genes in HeLa cells that had been transfected with pCAGGS encoding Tax~WT~, Tax~S240P~, or Tax~D247G,~ are presented in Figure [4](#F4){ref-type="fig"}. Representative qRT-PCR data were consistent with the data of microarrays in 7 validated cases (FOS, NR4A2, RORA, GEM, RRAD, TNFAIP6, and CYR61) in which Tax~D247G~ induced higher gene expression than Tax~WT~ and Tax~S240P~ did and in 1 validated case (JUN) in which the gene expression was similar for all 3 Tax proteins. However, the fold expression of the TNFAIP6 gene observed by the microarray analysis was higher than that in the qRT-PCR analysis. For instance, according to the microarray analysis, TNFAIP6 expression was upregulated 20.5-, 1.3-, and 36.6-fold in the presence of Tax~WT~, Tax~S240P~, and Tax~D247G~, respectively, compared with 5-, 2-, and 8-fold according to qRT-PCR. These qRT-PCR results confirmed that Tax~D247G~ induced strong responses of genes, whereas Tax~S240P~ induced the weakest responses among the 3 Tax proteins.

![**Validation of differentially expressed genes at the RNA and protein levels in HeLa cells.** Differential expression of up- ( **A**) or downregulated ( **B**) genes in HeLa cells transfected with pCAGGS encoding Flag-tagged Tax proteins (Tax~WT,~ open column; Tax~S240~, shaded column; Tax~D247G~, black column) or the control pCAGGS (light column) was validated by real-time RT-PCR. The bars indicate the fold change expression of the genes regulated by Tax. Data were normalized to GAPDH mRNA expression. The results represent the mean of 2 samples from 1 experiment. (**C**) Protein expressions of Tax, Fos, Rora, Rrad, Gem, and Tnfaip6 were validated by western blotting. Actin was used as a control.](1471-2164-13-121-4){#F4}

We next validated the results of the genes that were downregulated in Tax-expressing HeLa cells. For this purpose, we selected genes related to transcription/translation/RNA processing (ID2), immune response/response to virus (IFIT1 and IFIT3), and apoptosis (TNFSF10). As shown in Figure [4](#F4){ref-type="fig"}B, the expression of all of these genes were very low in the presence of Tax proteins, and there were no differences in the expression of these genes in the presence of wild-type and mutant Tax proteins, which perfectly correlated with our microarray results.

Finally, to further confirm that the changes observed at the RNA level were consistent at the protein level, we used western blotting to determine the expression of FOS, RORA, GEM, RRAD, TNFAIP6, and Actin as a control (Figure [4](#F4){ref-type="fig"}C). The results from this analysis indicate that Tax induced the overexpression of FOS, RORA, GEM, RRAD, and TNFAIP6; however, in the case of FOS, GEM, and TNFAIP6, the expression was higher in the presence of Tax~WT~ or Tax~D247G~ than in the presence of Tax~S240P~. However, Tax~S240P~ did not induce the overexpression of TNFAIP6. RRAD was highly overexpressed in the presence of Tax~D247G~, but there was no difference between the expression induced by Tax~WT~ and that induced by Tax~S240P~. By contrast, all of our Tax proteins induced similar levels of RORA expression. In general, all of these results were in agreement with the microarray results in HeLa cells, supporting the authenticity of our microarray data.

Validation of the expression of host cellular genes at the RNA and protein levels in bovine 23CLN cells
-------------------------------------------------------------------------------------------------------

Because our microarray analysis was performed in human cells and human arrays, we determined whether similar results could be obtained in bovine cells, the natural host for BLV. Therefore, we used bovine lymph node 23CLN cells for the purpose of this study. First, to detect protein expression and localization in 23CLN cells, pCAGGS vectors encoding Tax proteins were transfected into 23CLN cells, and then, the cells were subjected to confocal laser-scanning analysis and western blotting. As shown in Figure [5](#F5){ref-type="fig"}A, all 3 proteins localized predominantly to the cytoplasm, with lesser amounts detected in the nucleus, as observed for HeLa cells (Figure [1](#F1){ref-type="fig"}A). Western blotting analysis with the MAb M2 revealed that each Tax protein was expressed at detectable levels in the corresponding transfected 23CLN cells (Figure [5](#F5){ref-type="fig"}D). Moreover, Tax~WT~ and Tax~D247G~ were able to induce higher viral LTR-directed transcriptional activation than Tax~S240P~ (data not shown), similarly as observed in HeLa cells.

![**Validation of differentially expressed genes at the RNA and protein levels in bovine 23CLN cells.** 23CLN cells were transfected with pCAGGS encoding Flag-tagged Tax proteins (Tax~WT,~ open column; Tax~S240~, shaded column; Tax~D247G~, black column) or the control pCAGGS (light column). Thereafter, 24 h after transfection, cells were subjected to confocal laser-scanning analysis to detect localization (**A**) and to real-time RT-PCR ( **B** and **C**) and western blotting ( **D**) to validate in bovine cells differential expression of cellular genes had altered after expression of wild-type and mutant Tax proteins in HeLa cells. The bars indicate the fold change expression of up- ( **B**) or downregulated ( **C**) genes regulated by Tax. Data were normalized to GAPDH mRNA expression. The results represent the mean of 2 samples from 1 experiment. ( **D**) The protein expression of Tax and Fos, Rrad, and Tnfaip6 was validated by western blotting. Actin was used as a control.](1471-2164-13-121-5){#F5}

Later, we examined in Tax-expressing bovine cells the expression levels of factors, FOS, JUN, NR4A2, RORA, GEM, RRAD, TNFAIP6, and CYR61 genes, confirmed as being upregulated in Tax-expressing HeLa cells by qRT-PCR in Figure [4](#F4){ref-type="fig"}A (Figure [5](#F5){ref-type="fig"}B). It is important to mention that FOS and JUN were highly overexpressed in bovine cells compared to its expression in human cells. By contrast, it should also be noted that RORA, GEM, RRAD and TNFAIP6 genes which showed significantly high gene expression in human cells, were only slightly upregulated in 23CLN cells. Furthermore, four genes, ID2, IFIT1, IFIT3 and TNFSF10, were downregulated in the presence of Tax in 23CLN cells in accordance to our microarray data in HeLa cells; but surprisingly, only Tax~WT~ up-regulated the expression of IFIT3 with the two-hold increase as compared to the control sample (Figure [5](#F5){ref-type="fig"}C), indicating that only Tax~WT~ induced the up-regulation of expression of this gene related to immune response/response to virus in 23CLN cells. Finally, Western blotting with polyclonal antibodies against FOS, RRAD and TNFAIP6 showed the overexpression of these proteins in the presence of Tax in 23CLN cells and noticed that FOS expression was higher in the presence of Tax~WT~ or Tax~D247G~ than compared with the presence of Tax~S240P~ and RRAD and TNFAIP6 were mainly overexpressed in the presence of Tax~D247G~ (Figure [5](#F5){ref-type="fig"}D). From these results, we confirmed that the regulation of genes in bovine cells expressing Tax was similar to the microarray results observed in human cells.

Discussion
==========

Using interesting mutant forms of the BLV Tax protein with elevated (Tax~D247G~) or reduced (Tax~S240P~) transactivation activity in the replication and propagation of BLV \[[@B14]\], we identified cellular genes regulated by Tax protein by a large-scale host cell gene-profiling approach using human cDNA microarrays. Our results lead to 3 major conclusions as follows. (1) Several alterations in gene expression were observed after the expression of wild-type and mutant Tax proteins, including genes involved in transcription/translation/RNA processing, signal transduction, cell growth, apoptosis, stress response, and immune response. This clearly showed that BLV Tax protein has multiple biological effects on various cellular environments via the direct or indirect interaction of Tax with cellular partners. (2) Microarray data revealed that although all Tax proteins can induce gene expression changes in HeLa cells, the number and level of changes differ among the 3 Tax proteins. Particularly, Tax~D247G~ could induce high levels and large numbers of host gene expression changes, contrary to Tax~S240P~, which induced very low levels and small numbers of gene expression changes, suggesting a correlation between gene expression and the transactivation activity of these mutants, as previously reported \[[@B8],[@B14]\]. (3) The most interesting outcome of this study is the discovery that Tax and its mutants induced downregulation of expression of genes involved in the innate immune response. Moreover, genes related to the cellular stress response are also upreglated by Tax and this finding is particularly relevant to Tax~S240P.~ The previously identified functions of BLV Tax are the activation of viral transcription \[[@B2],[@B4]\], modulation of cellular genes related to the regulation of cell growth such as c-*fos*\[[@B8]\], induction of transformation and immortalization \[[@B10]\], regulation of apoptosis \[[@B16]\], inhibition of DNA repair \[[@B13]\] and promotion of cell survival \[[@B11],[@B17]\]. Therefore, these alterations in gene expression may suggest the presence of novel functions of the BLV Tax protein that are related with immune responses and stress responses.

Previously, we identified a series of mutant BLV Tax proteins, including Tax~D247G~ and Tax~S240P~, which exhibit strikingly enhanced ability to stimulate or reduce viral LTR-directed transcription than the wild-type protein \[[@B8]\]. All of the mutants have at least 1 amino acid substitution between amino acids 240 and 265, and the CRE motif in the BLV LTR is sufficient for transactivation by the Tax mutants. Transient expression analysis revealed that Tax~D247G~, which had the strongest transactivation activity, more strongly increased the production of viral protein and particles from a defective recombinant proviral clone of BLV than the wild-type Tax did; conversely, Tax~S240P~ was unable to induce the release of viral particles. The present study shows that for half of the genes listed in Table [1](#T1){ref-type="table"}, Tax~D247G~ induced higher gene expression than Tax~WT~ and Tax~S240P~ did, and for many of these genes, with exceptions for genes related with stress responses, were expressed at the lowest levels in Tax~S240P~-transfected cells. These results indicate that in addition to the transactivation activity of BLV LTR, the expression of cellular genes might be limited or negatively regulated by the region of the BLV Tax protein between amino acids 240 and 265 and that the substitution D247G might act to circumvent this inhibitory activity. Furthermore, Tax~D247G~, but not Tax~S240P~, was found to activate other retroviral enhancers that are not activated or are only very slightly activated by the wild-type protein \[[@B14]\]. Moreover, Tax~D247G~ transfection resulted in remarkably increased levels of endogenous c-*fos* mRNA in both human and bovine cell lines \[[@B8]\]. Conversely, the wild-type Tax protein cannot activate the expression of human c-*fos*, indicating that wild-type BLV Tax might discriminate between human and bovine c- *fos* promoter sequences. Interestingly, we found that Tax~D247G~ regulated more genes involved in transcription, signal transduction, immune responses, cell growth, apoptosis, cell adhesion, transport, metabolic processes, phosphorylation, and other functions than Tax~WT~ and Tax~S240P~ did. By contrast, the expression of heat-shock proteins (HSPs) such as DNAJB1, HSPA1A, and HSPA6, which are upregulated when cells are exposed to elevated temperatures or other stress \[[@B19]\], is significantly increased in the presence of Tax~S240P~ compared with that in the presence of other Tax proteins, indicating that BLV Tax may directly or indirectly be involved in stress response. These findings raised the possibility that the target sequence specificity of BLV Tax might be limited by the region of the protein between amino acids 240-265. Thus, the mutant proteins might have the ability to activate various cellular genes that might be barely activated, if at all, by wild-type Tax. Therefore, mutant forms of the BLV Tax protein, such as Tax~D247G~ and Tax~S240~, might be useful tools for elucidating the mechanism of known and novel functions induced by Tax expression. Our data also demonstrate the significant differences in the activating potential of Tax~WT~, Tax~D247G,~ and Tax~S240~, given that global changes in celluar gene expression are likely to critical to the transforming activity of these Tax mutants.

Our microarray data and qRT-PCR analysis clearly revealed that Tax transfection resulted in overexpression of FOS, and its mRNA expression level was much higher in bovine cells than in human cells. Western blotting also revealed the overexpression of FOS in the presence of Tax in both bovine 23CLN cells and HeLa cells. Furthermore, musculoaponeurotic fibrosarcoma (MAF) proteins, such as MAFB and MAFF, and JUN were significantly upregulated in the presence of Tax proteins (Table [1](#T1){ref-type="table"}). Moreover, ATF-2 transcriptional factor network was significantly detected as the Tax-related signaling pathway by GeneSpring software (Table [3](#T3){ref-type="table"}). It is well known that FOS, JUN, MAF, and ATF belong to the activator protein 1 (AP-1) transcription factor family \[[@B20]\]. AP-1 is a dimeric complex composed of JUN, FOS, MAF, and ATF protein families. This AP-1 complex can form many different combinations of heterodimers and homodimers, and different AP-1 dimers control transcriptional activation or suppression of a variety of genes involved in the regulation of proliferation, differentiation, apoptosis, and transformation. Some members of the CREB protein families are also part of AP-1 complexes. Indeed, CREM, which is member of the CREB family, and ETS oncogene transcription family member ETV5 \[[@B21]\], which is known to cooperate with AP-1, were upregulated by Tax protein (Table [1](#T1){ref-type="table"}). As shown in Table [3](#T3){ref-type="table"}, signaling pathways regulated by Tax appeared to be involved in many transcriptional factor networks related to AP-1, such as Wnt-mediated signaling, MAP kinase signaling, IL1-, IL-2-, and IL12-mediated signaling, calcium signaling, and RAS signaling. These results were supported by previous results that the expression of the FOS gene is modulated by BLV Tax protein \[[@B8],[@B12],[@B22]\], and in addition, BLV Tax protein could mediate transactivation of the viral genome through increased binding of the cellular proteins CREB, ATF-1, and ATF-2 to the TxREs \[[@B6],[@B23]\]. Furthermore, results were confirmed by studies that reported that HTLV-1-Tax induced the expression of various family members of AP-1 such as c-JUN, JUN-D, c-FOS, and FRA-1 in T cells at the level of transcription through the AP-1-binding site, and upregulated genes contributed to the initial steps of the transformation process \[[@B24]\]. Thus, our findings raise the possibility that Tax mainly activates AP-1 signaling pathways via interactions with other transcriptional pathways, thereby stimulating the production of viral transcripts and induction of cellular genes.

The upregulation of AP-1 via direct overexpression or oncogenic RAS was found to correlate with a positive effect on cell transformation \[[@B25]\]. We showed that Tax protein activates nucleotide-binding proteins (G-Protein) such as GNB5 \[[@B26]\], GNG4 \[[@B27]\], RGS2 \[[@B28]\], and RGS16 \[[@B29]\] and GTP-binding proteins such as GEM \[[@B30]\] and RRAD \[[@B31]\]. Ras-related GTP-binding proteins comprise a superfamily consisting of many members that play important roles in cell proliferation and differentiation \[[@B32]\], cell cycle regulation \[[@B33]\], and glucose transport into cells \[[@B31],[@B34]\]. It is known that these Ras-related GTP-binding proteins are linked with the AP-1 pathway. Interestingly, there is increasing evidence that the aberrant activity of numerous members of the Ras superfamily of small GTPases contributes to cancer growth, invasion, and metastasis \[[@B35]\]; as an example, RRAD overexpression in tumor tissue has been associated with poor prognosis among breast cancer patients \[[@B36]\]. Previously, Tax was reported to cooperate with the Ha-*ras* oncogene to induce the full transformation of cells that form tumors when it was injected into nude mice \[[@B10]\]. Thus, our results suggest a compromise of RAS superfamily such as GEM and RRAD expression in the mechanism leading to tumorigenesis by Tax.

Arguably the most surprising and significant finding of this study is that Tax protein transfection resulted in the up- and downregulation of genes related to the immune response, suggesting a novel function of BLV Tax protein, which can regulate immune response. In addition, all Tax variants down-regulated the expression of the T-cell specific factor GATA3, a notable difference with HTLV-1 Tax which cooperates together with ETS1/2 and GATA3 to activate the production of IL-5 \[[@B37]\]. The downregulated genes mainly belonged to the interferon family of anti-viral factors, such as IFI44, IFIH1, IFIT1, IFIT2, IFIT3, and ISG15. Interferons have emerged as major components of the innate immune system, and they are recognized for their antiviral function in addition to their antiproliferative and immunomodulatory effects on cells \[[@B38]\]. For BLV, IFNγ has mainly been detected to suppress viral replication \[[@B39]-[@B41]\]. In human immunodeficiency virus type 1 (HIV-1), IFNs have been implicated in blocking both early and late stages of the HIV-1 lifecycle \[[@B42],[@B43]\]. IFIT1, an interferon-stimulated gene (ISG), has also been implicated in the antiviral actions of IFNs\[[@B44]\] against hepatitis C virus, West Nile virus, lymphocytic choriomeningitis virus, parainfluenza 1 virus, vesicular stomatitis virus, and encephalomyocarditis virus \[[@B45]-[@B47]\]. It has also been reported that ISG15 plays an important role in inhibiting bovine immunodeficiency virus replication in fetal bovine lung cells, and its expression has been associated with antiviral function \[[@B48]\]. IFIT3 was recently described as a key element of the antiproliferative and antiviral activity of IFNα \[[@B49]-[@B51]\]. Because these molecules have a primary role in antiviral function and we showed that they were all downregulated at similar levels by three Tax proteins in human and bovine cells except for up-regulation of IFIT3 gene by Tax~WT~ in bovine 23CLN cells, it appears that Tax suppresses the innate immune response to promote persistence and transmission of BLV. Indeed, we previously found no significant differences in the viral load and the expression of viral RNA for 28 weeks between sheep experimentally injected with BLVs that encode the wild-type and mutant Tax~D247G~ proteins, in contrast to *in vitro* that Tax~D247G~ produced more viral proteins and particles, and was transmitted very effectively \[[@B15]\], suggesting that Tax~WT~ and Tax~D247G~ which possess different transactivation abilities for BLV LTR and cellular proto-oncogene c-*fos*, might suppress similarly expression of genes involved in the immune response *in vivo* as well as our microarray results *,* thereby promoting expansion and infection of BLV on equal level *in vivo*.

The Tax-upregulated gene related to the immune response is TNFAIP6 (tumour necrosis factor alpha inductor protein 6; TSG-6). This gene is not constitutively expressed in healthy adult tissues, but it has been observed in physiological and pathological contexts that are associated with inflammation and tissue remodeling \[[@B52],[@B53]\]; for example, TNFAIP6 has been observed in cultured human uterine cervical fibroblasts, in which it is upregulated in response to IL-1 and TNF-α \[[@B54]\]. In BLV replication, an important role for TNF-α has been suggested in the elimination of BLV during the early stage of infection and in the progression of disease during the lymphocytosis stage \[[@B41],[@B55]-[@B57]\]. Moreover, it has clearly been demonstrated that the lack of TNF-α expression enhanced the persistence of BLV infection in TNF-α^-/-^ mice \[[@B58]\]. In contrast to TNFα, the role of TNFAIP6 in BLV infection is unknown. Nevertheless, as TNFAIP6 is upregulated in response to TNF-α, there is a possibility that TNFAIP6 may regulate the disease progression of BLV-induced leukemogenesis. Importantly, HTLV-1 dampens the TNFα response to promote persistence of HTLV-1 infection \[[@B59]\]. Moreover, TNFα shows promise as part of a combined therapy for the treatment of HTLV-1 induced adult T cell Leukemia \[[@B60]\]. Therefore, our data are likely to be important in understanding both BLV and HTLV-1 persistence in infected hosts and suggest possible strategies to improve therapies for BLV and HTLV-1-induced disease. Collectively, further investigation is required to define the role of Tax in immune responses and the function of the genes related to immune responses in BLV and HTLV-1 pathogeneses.

Genes that are up- or downregulated in the presence of Tax are likely to play important roles in transcription, signal transduction, cell growth, apoptosis, stress responses, and immune responses. Although these results were obtained using a human cDNA microarray system, we believe that the use of mutant Tax proteins (Tax~D247G~ and Tax~S240P~) in human cells is the best available system to begin preliminary studies on the effects of Tax on transformation during BLV and HTLV-1 infections. Indeed, although it may be noted to show the different expression patterns in several factors, such as FOS, JUN, RORA, GEM, RRAD, TNFAIP6 and IFIT3 genes in human and bovine cells, we could validate that the regulation of genes in bovine cells expressing Tax was similar to the microarray results observed in human cells in this study. However, we also assume that a number of genes is not equally expressed in different cell lines and/or *in vivo*. At this point, the extent of these effects and the manner in which they may be interrelated with the induction of BLV and HTLV-1 induced lymphoma or the regulation of disease progression are not known. A detailed study addressing the direct and indirect effects of Tax-mediated transformation is needed to gain a better understanding of the contribution of Tax to BLV and HTLV-1 pathogenesis. Our findings also lend some additional support to the hypothesis that viruses have evolved mechanisms of changing the host cellular milieu to facilitate viral replication and pathogenesis strategies that can be investigated at a mechanistic level, and our data suggest additional avenues for the development of novel antiretroviral therapeutics.

Conclusion
==========

By undertaking a comparative analysis of the BLV Tax protein with elevated (Tax~D247G~) or reduced (Tax~S240P~) transactivation activity, we found that Tax exerts a significant impact on cellular functions as diverse as transcription, translation, RNA processing, signal transduction, cell growth, apoptosis, stress response and immune response. Importantly, to our knowledge, our study is the first report that shows the extent to which BLV Tax regulates the innate immune response and it is likely that this tactic ensures ongoing viral replication and viral persistence even in the face of a strong host immune response. From our data, we suggest that understanding the molecular mechanisms used by BLV and HTLV-1 to thwart the immune response will lead to new avenues for the development of novel and effective antiretroviral therapeutics.

Methods
=======

Cells and transfection
----------------------

Human cervical HeLa and bovine lymph node 23CLN cells were maintained in DMEM medium (Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 100 units/mL penicillin/streptomycin (Sigma). For transient transfection, cells were transfected with Tax wild-type or mutant expression vectors by using FuGENE HD (Roche) according to the manufacturer's instructions.

Construction of plasmids
------------------------

The Tax genes were amplified from pME18Neo encoding wild-type (Tax~WT~) and mutant (S240P (Tax~S240P~) and D247G (Tax~D247G~)) Tax proteins by using the primers BTaxF (5^′^-AA[CTCGAG]{.ul}GCCACCATGGCAAGTGTTGTTGGTTGGGGGCC-3^′^) and  BTaxR (5^′^-AA[GCGCCGC]{.ul}TCACTTGTCGTCATCGTCTTTGTAGTCAAAAAGGCGGGAGAGCC-3^′^). The underlined sequences in the forward and reverse primers correspond to the restriction sites for *Xho*I and *Not*I, respectively, and the Flag sequence was included at the 3^′^ end of all Tax genes. PCR products were then introduced into the *Xho*I and *Not*I sites of the pCAGGS mammalian vector \[[@B61]\]. The pGV-BLTR reporter plasmid has been described previously \[[@B14]\]. The pRL-SV40 plasmid (Promega), which encodes a *Renilla* luciferase gene, was used for normalization of the efficiencies of transfection.

Luciferase assay
----------------

HeLa and 23CLN cells were seeded into 24-well plates 24 h before transfection at a density of 1 × 10^5^ cells per well. Cells were transfected with 1 μg of each Tax vector, 0.5 μg of pGV-BLTR, and 0.5 μg of pRL-SV40 by using FuGENE HD, according to the manufacturer's instructions. Luciferase activity was measured 24 h after transfection by using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol. The firefly luciferase reporter and the *Renilla* luciferase reactions were measured using a multilabel counter (Model 1420, Wallac Arvo, Perkin Elmer Life Sciences). Relative luciferase activity was calculated as firefly/ *Renilla* luciferase activity, and the luciferase activity of each construct was compared with that of the pGV-BLTR vector. All experiments were conducted in duplicate at 3 different times.

Immunofluorescence
------------------

HeLa and 23CLN cells were seeded onto 22-mm-diameter coverslips in 24-well plates 24 h before transfection, at a density of 1 × 10^5^ cells/well. After 24 h of transfection with each Tax vector or control vector, cells were washed twice with phosphate-buffered saline (PBS), fixed in 3.7% formaldehyde, permeabilized using 0.2% Triton X-100, and stained using an anti-Flag M2 MAb (Sigma), followed by an anti-mouse IgG~1~ Alexa 488 antibody (Molecular Probes). Nuclei were stained using Hoechst 33342 (Sigma). Subcellular localization was determined using an Olympus fluorescence microscope (Olympus, FV1000).

RNA extraction
--------------

After 24 h of transfection with each Tax vector or control vector, some cells were analyzed by Immunofluorescence. RNA was isolated from total cell extracts of HeLa or 23CLN cells by using an RNeasy Mini Kit (Qiagen) according to the manufacturer\'s instructions at 30 h posttransfection when the expression efficiency was greater than 30% in all transfections. For high quality of the RNA, the protocol included the remove of residual DNA in the sample. RNA was quantified using a spectrophotometer and then stored at −80°C. For gene-chip analysis, the quality of RNA was tested using the Agilent Bioanalyser (Agilent Technologies) runs.

Microarray analysis
-------------------

RNA samples were run once on microarray using the HGU133A 2.0 Affymetrix chip. Microarray hybridization and fluorescence detection were performed as described in the Affymetrix Gene-Chip Expression Analysis Technical Manual. Microarray data analyses were subjected to bioinformatics process to identify statistically significant changes in gene expression between samples by using GeneSpring GX 11.0 software (Agilent Technologies). Microarray data have been deposited in NCBI's Gene Expression Omnibus and assigned GEO Series accession number GSE35823. We obtained fold changes in gene expression, hierarchical clustering, and gene ontology annotations, and revealed which pathways were significantly up- or downregulated (p \< 0.05).

qRT-PCR
-------

After 30 h of transfection with each Tax vector or control vector, cells were lysed, and total RNA was prepared using the RNeasy Mini Kit (Qiagen). RT-PCR was performed using specific primers for the targets and OneStep SYBR Green PCR mix (Takara), according to the manufacturer's manual. qRT-PCR was performed using a Prism 7500 sequence detection system (Applied Biosystems). Samples were run in duplicates and all data were normalized to GAPDH mRNA expression.

Western blot analysis
---------------------

After 30 h of transfection with each Tax vector or control vector, cells were lysed, separated through a 6--10% sodium dodecyl (SDS)-polyacrylamide gel, and then transferred to a PVDF membrane (Immobilon-P, Millipore Corp.) using a Trans-blot SD semi-dry transfer cell (Bio-Rad). After the transfer, the membranes were blocked in a 5% non-fat dry milk in PBS and 0.1% Tween-20 and then incubated with a 1:1000 dilution of primary antibody anti-Flag M2 MAb (Sigma) or a 1:300 dilution in the case of FOS (K-25), RORA (X-23), GEM (G-1), RRAD (D-15), TSG-6 (N-20), or Actin (c-11) antibodies; all antibodies were obtained from Santa Cruz Biotechnology. Thereafter, the membranes were washed and incubated either with anti-mouse, anti-rabbit, or anti-goat horseradish peroxidase-conjugated secondary antibody (Jackson, Immuno Research) and developed using the SuperSignal West Pico Chemiluminescent substrate Kit (Pierce).
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